Searched for
OFFICE OF CLINICAL INTEGRITY
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- Travel insurance versus overseas student health cover: What Indian students need to knowIndian students studying in Australia must secure Overseas Student Health Cover (OSHC) for visa compliance and medical needs. While not man...
- Saving supply chains from climate shocks is a lure for investorsCompanies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...
- Hexagon Nutrition IPO opens June 5: Price band fixed at Rs 42-45; check key details hereHexagon Nutrition Limited is launching its Initial Public Offering on June 5, 2026. The company plans to raise Rs 138.87 crore through an O...
- A massive DNA discovery just rewrote everything we thought we knew about the Japanese peopleA groundbreaking DNA study has uncovered evidence of a third ancestral group contributing to Japan's population, originating from northeast...
- Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answerThe gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath br...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- Bajaj Group to enter healthcare biz with Rs 2k cr bet in Pune; expand to 7 cities in a decadeThe Bajaj group is entering the healthcare sector. A significant investment of over Rs 2,000 crore is planned for Pune over the next three ...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- Tooth regeneration therapy enters first human clinical trials in JapanA groundbreaking human trial in Japan is exploring a revolutionary treatment to regrow teeth. Researchers have identified a way to activate...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%It is not every day that you see crude oil prices moving higher and the Asian markets, including India, also inching higher. Now, as an inv...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%If you are putting fresh money into the market, it might be a good idea to stay with companies that don't have much to do with global suppl...
- ET Women Conclave 2026 spotlights leadership, reinvention, and powerful conversationsThe ET Women Conclave 2026, presented by Dalcore Projects Pvt. Ltd., convened leaders and changemakers at Grand Hyatt Gurgaon to celebrate ...
- Manage short-term risk and volatility for long-term opportunity: 7 stocks from different sectors with upside potential of up to 32%There will be many ifs and buts – and a high volatility quotient – when a market is in its initial phase of correction, especially a correc...
- IHH Healthcare aims to hike its stake in Fortis to 50%: CEO Prem Kumar NairIHH Healthcare sees India as a major growth market. The company plans to increase its stake in Fortis Healthcare. IHH aims to expand its ho...
- Kyvex announces strategic partnership with IPL player Vaibhav Arora of KKRKyvex, founded by Indian entrepreneur Pearl Kapur alongside Chief Technology Officer Ravindra Varna, today announced a strategic partnershi...
- CVS removes popular cough and cold medicines from store shelvesCVS has removed popular oral cough and cold medicines like Sudafed, Mucinex, Vicks, Allegra, and Dayquil from its stores. The FDA advisory ...
- India to unveil new drug policy: OfficialsA team of Indian officials led by G N Singh, Drug Controller General of India, said a set of new procedures to facilitate clinical trials a...
- Unique code to define patient's medical history in pipelineThe Health Ministry has included Systematised Nomenclature of Medicine- Clinical Terms as the standard for clinical vocabulary for use in m...
Load More
